/
HIMS
$28.15-$0.62 (-2.16%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$7.0B
233M shares
52-week range
$13.74 – $65.30
28% from low
Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Exchange
NYSE
CS
Change+$20.68
Hims & Hers Health, Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
www.forhims.com- Employees
- 2,442
- IPO / List date
- Jan 21, 2021
- HQ
- SAN FRANCISCO, CA
Held by traders on TradeandTell
No one on the platform currently holds HIMS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,118,080 | $44.0M |
| Bridgewater Associatesas of 2026-03-31 | 41,562 | $862.8K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HIMS yet.
